|
"tseng lm"的相关文件
显示项目 1-15 / 15 (共1页)
1
每页显示[10|25|50]项目
| 國家衛生研究院 |
2024-04-17 |
Spatial and single-cell explorations uncover prognostic significance and immunological functions of mitochondrial calcium uniporter in breast cancer
|
Li, CJ;Tzeng, YDT;Hsiao, JH;Tseng, LM;Hsu, TS;Chu, PY |
| 國家衛生研究院 |
2021-02-04 |
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer in the APHINITY trial: 6 years' follow-up
|
Piccart, M;Procter, M;Fumagalli, D;de Azambuja, E;Clark, E;Ewer, MS;Restuccia, E;Jerusalem, G;Dent, S;Reaby, L;Bonnefoi, H;Krop, I;Liu, TW;Pieńkowski, T;Toi, M;Wilcken, N;Andersson, M;Im, YH;Tseng, LM;Lueck, HJ;Colleoni, M;Monturus, E;Sicoe, M;Guillaume, S;Bines, J;Gelber, RD;Viale, G;Thomssen, C; the APHINITY Steering Committee and Investigators |
| 國家衛生研究院 |
2020-07-22 |
Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: Phase II randomized, placebo-controlled study
|
Huang, CS;Yu, AL;Tseng, LM;Chow, LWC;Hou, MF;Hurvitz, SA;Schwab, RB;J, LM;Chang, HK;Chang, HT;Chen, SC;Kim, SB;Hung, JT;Ueng, SH;Lee, SH;Chen, CC;Rugo, HS |
| 國家衛生研究院 |
2020-02 |
Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in pat
|
Piccart, M;Procter, M;Fumagalli, D;de Azambuja, E;Clark, E;Ewer, MS;Restuccia, E;Jerusalem, G;Dent, S;Reaby, L;Bonnefoi, H;Krop, I;Liu, TW;Pienkowski, T;Toi, M;Wilcken, N;Andersson, M;Im, YH;Tseng, LM;Lueck, HJ;Colleoni, M;Monturus, E;Sicoe, M;Guillaume, S;Bines, J;Gelber, R;Viale, G;Thomssen, C |
| 國家衛生研究院 |
2017-08 |
Overexpression of phosphoprotein phosphatase 2A predicts worse prognosis in patients with breast cancer: A 15-year follow-up
|
Chen, PM;Chu, PY;Tung, SL;Liu, CY;Tsai, YF;Lin, YS;Wang, WL;Wang, YL;Lien, PJ;Chao, TC;Tseng, LM |
| 國立臺灣海洋大學 |
2013-04 |
Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
|
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J |
| 臺北醫學大學 |
2013 |
Increases in Xu Zheng and Yu Zheng among Patients with Breast Cancer Receiving Different Anticancer Drug Therapies
|
Huang, SM;Chien, LY;Tai, CJ;Tseng, LM;Chen, PH;Tai, CJ |
| 國立臺灣海洋大學 |
2008 |
Mitochondrial Stress-induced Nuclear Genomic Alterations in Human Cancer Cells
|
Chang CJ;Yin PH;Tseng LM;Chi CW;Wei YH;Lee HC |
| 國立臺灣海洋大學 |
2008 |
Genes, Pathways and Invasive Behavior Associated with Mitochondrial Stress on Human Breast Cancer Cells
|
Chang CJ;Yin PH;Tseng LM;Chi CW;Wei YH;Lee HC |
| 國家衛生研究院 |
2007-12 |
Topoisomerase 2 alpha gene amplification and protein expression in fresh and recurrent breast cancers
|
Tseng, LM;Liu, JM;Lan, C;Lin, LC;Hsu, DH;Chang, CP;Kao, HL |
| 國立臺灣海洋大學 |
2007 |
The Role of Mitochondrial Stress on Breast Cancer Cell Progression
|
Chang CJ;Tseng LM;Yin PH;Chi CW;Lee HC |
| 國家衛生研究院 |
2006-09 |
Comprehensive breast cancer adjuvant digital summary
|
Liu, JM; Wu, HW; Tiu, CM; Tseng, LM; Yen, SH; Shiau, CY; Lan, C; Li, AFY |
| 國家衛生研究院 |
2006-05 |
Angiogenic and morphological response of locally advanced breast cancer to neoadjuvant chemotherapy: Color Doppler ultrasound evaluation
|
Tiu, CM;Chou, YH;Chiou, SY;Tseng, LM;Liu, JM |
| 國家衛生研究院 |
2001-05 |
Tie-1 tyrosine kinase is an independent prognostic indicator for invasive breast cancer
|
Tseng, LM; Hsu, CY; Wang, HC; Liu, JM; Chang, HM; Lo, SS; Wu, CW; Lui, WY; Chi, CW |
| 中國醫藥大學 |
2001 |
Tie-1 tyrosine kinase is an independent prognostic indicator for invasive breast cancer
|
Tseng, LM; Hsu, CY; Wang, HC; Liu, JM; Chang, HM; Lo, SS; Wu, CW; Lui, WY; Chi, CW |
显示项目 1-15 / 15 (共1页)
1
每页显示[10|25|50]项目
|
